BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20721654)

  • 61. Long-term follow-up of nephrotoxicity in rats administered both melamine and cyanuric acid.
    Yasui T; Kobayashi T; Okada A; Hamamoto S; Hirose M; Mizuno K; Kubota Y; Umemoto Y; Kawai N; Tozawa K; Gao B; Kohri K
    BMC Res Notes; 2014 Feb; 7():87. PubMed ID: 24507656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Kidney stone distribution caused by melamine and cyanuric acid in rats.
    Chen YT; Jiann BP; Wu CH; Wu JH; Chang SC; Chien MS; Hsuan SL; Lin YL; Chen TH; Tsai FJ; Liao JW
    Clin Chim Acta; 2014 Mar; 430():96-103. PubMed ID: 24418618
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic tools for detection of intoxication by melamine and its analogue.
    Wong CK; Chan MH; Kwok JS; Ho CS; Ng PC; Suen SH; Fung KP; Lau CM; Fok TF
    Hong Kong Med J; 2013 Dec; 19 Suppl 8():12-5. PubMed ID: 24473521
    [No Abstract]   [Full Text] [Related]  

  • 64. Melamine-contaminated powdered formula and urolithiasis.
    Hocking B
    N Engl J Med; 2009 Jun; 360(25):2676-7; author reply 2677-8. PubMed ID: 19537319
    [No Abstract]   [Full Text] [Related]  

  • 65. [Risk factors of melamine-contaminated milk powder related urolithiasis: a multicenter nested case-control study].
    Guan N; Yao C; Huang SM; Hu BJ; Zhang DF; Fang QW; Fan QF; Xu GB; Zhu SN; Zhang AH; Liu H; Liu L; Zhang GM; Tao LY; Chang YM; Liu XY; Ai Y; Zhao YM; Ding J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):690-6. PubMed ID: 21170101
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors for acute kidney injury (AKI) in infants with melamine-associated urolithiasis and follow-up: a multi-center retrospective analysis.
    He Q; Yue Z; Tang X; Chang H; Wang W; Shi W; Wang Z; Shang P
    Ren Fail; 2014 Oct; 36(9):1366-70. PubMed ID: 25155621
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Public-health risks of melamine in milk products.
    Chan EY; Griffiths SM; Chan CW
    Lancet; 2008 Oct; 372(9648):1444-5. PubMed ID: 18970965
    [No Abstract]   [Full Text] [Related]  

  • 68. FDA updates health information advisory on melamine contamination.
    Lang L
    Gastroenterology; 2008 Nov; 135(5):1441. PubMed ID: 18848834
    [No Abstract]   [Full Text] [Related]  

  • 69. Repeat oral dose toxicity studies of melamine in rats and monkeys.
    Early RJ; Yu H; Mu XP; Xu H; Guo L; Kong Q; Zhou J; He B; Yang X; Huang H; Hu E; Jiang Y
    Arch Toxicol; 2013 Mar; 87(3):517-27. PubMed ID: 23052191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of melamine-associated urinary stones in children with consumption of melamine-contaminated infant formula.
    Chang H; Shi X; Shen W; Wang W; Yue Z
    Clin Chim Acta; 2012 Jun; 413(11-12):985-91. PubMed ID: 22402311
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Management of pediatric urolithiasis induced by melamine-contaminated powdered formula (report of 619 cases).
    Panfeng S; Hong C; Zhongjin Y; Wei Z; Wenhui L; Baoguang S; Junsheng B; Liingjun Z; Zizhen H
    Urology; 2011 Aug; 78(2):411-6. PubMed ID: 21497378
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nephrotoxicity of mala fide melamine: modern era milk scandal.
    Lattupalli R; Yee J; Kolluru A
    ScientificWorldJournal; 2008 Oct; 8():949-50. PubMed ID: 18836663
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Beyond melamine: more reasons not to use animal milk in infant feeding.
    Greiner T
    J Hum Lact; 2009 Nov; 25(4):397-9. PubMed ID: 19625632
    [No Abstract]   [Full Text] [Related]  

  • 74. [Follow-up study on children with urinary calculi associated with exposure to melamine-contaminated formula].
    Chang YM; Tong XM; Wang XL; Zhao YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):278-9. PubMed ID: 20416220
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utility of CT Scan in detection of melamine--associated urinary stones.
    Hu P; Lu L; Qin YH; Hu B
    Indian J Pediatr; 2010 Dec; 77(12):1405-8. PubMed ID: 20821278
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A No Observable Adverse Effects Level (NOAEL) for pigs fed melamine and cyanuric acid.
    Stine CB; Reimschuessel R; Gieseker CM; Evans ER; Mayer TD; Hasbrouck NR; Tall E; Boehmer J; Gamboa da Costa G; Ward JL
    Regul Toxicol Pharmacol; 2011 Aug; 60(3):363-72. PubMed ID: 21620919
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Melamine: the world at your doorstep.
    Morin KH
    MCN Am J Matern Child Nurs; 2009; 34(4):261. PubMed ID: 19587573
    [No Abstract]   [Full Text] [Related]  

  • 78. [Investigation of typical melamine urinary stones using infrared spectra].
    Si MZ; Li QY; Liu RM; Kang YP; Wang KH; Zhang ZG
    Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Feb; 30(2):363-7. PubMed ID: 20384125
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melamine-contaminated powdered formula and urolithiasis.
    Dharnidharka VR
    N Engl J Med; 2009 Jun; 360(25):2676; author reply 2677-8. PubMed ID: 19537318
    [No Abstract]   [Full Text] [Related]  

  • 80. One-year follow-up of patients with melamine-induced urolithiasis in Southwest China.
    Dai Q; Jiang Y; Tu W; Luo H; Wang Z; Lau YL; Shi H; Yang H
    Int J Environ Health Res; 2012; 22(5):450-7. PubMed ID: 22233377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.